Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,170 JPY | +2.42% | +7.49% | +1.77% |
May. 08 | Taiyo Yuden's Attributable Profit up or down 64% in Fiscal 2024 | MT |
May. 01 | Taiyo Koki to Present CVG-6 at 2024 Grinding Hub in Pursuit of 20 Billion Yen Sales Target | MT |
Business Summary
Number of employees: 2,120
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Electronics
70.3
%
| 71,093 | 72.6 % | 68,419 | 70.3 % | -3.76% |
Medical and Pharmaceutical
26.1
%
| 23,467 | 24.0 % | 25,447 | 26.1 % | +8.44% |
Others
3.6
%
| 3,405 | 3.5 % | 3,472 | 3.6 % | +1.97% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
35.3
%
| 37,019 | 37.8 % | 34,378 | 35.3 % | -7.13% |
Japan
34.8
%
| 32,472 | 33.1 % | 33,885 | 34.8 % | +4.35% |
South Korea
16.2
%
| 15,294 | 15.6 % | 15,810 | 16.2 % | +3.37% |
Taiwan
7.5
%
| 8,162 | 8.3 % | 7,328 | 7.5 % | -10.22% |
Others
6.1
%
| 5,018 | 5.1 % | 5,936 | 6.1 % | +18.29% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eiji Sato
CEO | Chief Executive Officer | 55 | 08-05-31 |
Eiji Takehara
CHM | Chairman | 60 | 86-03-31 |
Shoji Minegishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hitoshi Saito
BRD | Director/Board Member | 59 | 96-08-31 |
Masayuki Hizume
BRD | Director/Board Member | 61 | 94-05-31 |
Shuichi Omi
IRC | Investor Relations Contact | - | - |
Kaori Terunuma
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - | |
Takuji Maekawa
PRN | Corporate Officer/Principal | - | 19-06-05 |
Masaru Ohki
AUD | Comptroller/Controller/Auditor | 66 | 82-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eiji Sato
CEO | Chief Executive Officer | 55 | 08-05-31 |
Tomoyuki Tanaka
BRD | Director/Board Member | - | - |
Masayuki Hizume
BRD | Director/Board Member | 61 | 94-05-31 |
Hitoshi Saito
BRD | Director/Board Member | 59 | 96-08-31 |
Keiko Tsuchiya
BRD | Director/Board Member | 64 | 17-05-31 |
Eiji Takehara
CHM | Chairman | 60 | 86-03-31 |
Asako Aoyama
BRD | Director/Board Member | - | - |
Yumiko Kamada
BRD | Director/Board Member | 58 | - |
Masao Arima
BRD | Director/Board Member | - | - |
Tomoyuki Tanaka
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 58,291,559 | 36,169,521 ( 62.05 %) | 2,366,038 ( 4.059 %) | 62.05 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
TAIYO HOLDINGS CO., LTD. 4.06% | 2,366,038 | 4.06% | 52,997,240 $ |
CYFUSE BIOMEDICAL K.K. 3.80% | 300,000 | 3.80% | 1,445,043 $ |
Company contact information
Taiyo Holdings Co., Ltd.
Metropolitan Plaza Bldg., 16/F 1-11-1 Nishiikebukuro
171-0021, Tokyo
+
http://www.taiyo-hd.co.jpSales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.77% | 1.11B | |
+17.59% | 66.6B | |
+0.84% | 48.75B | |
+17.11% | 41.45B | |
+22.26% | 26.74B | |
+11.45% | 19.55B | |
+5.08% | 18.21B | |
-21.31% | 16.02B | |
+4.12% | 15.62B | |
-9.70% | 15.33B |
- Stock Market
- Equities
- 4626 Stock
- Company Taiyo Holdings Co., Ltd.